Cargando…

Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer

SIMPLE SUMMARY: Breast cancer is currently the most common type of diagnosed cancer worldwide. Noninvasive imaging of therapeutic targets or biomarkers for breast cancer has the potential to contribute to precision medicine, where targeted therapy is needed. Positron emission tomography (PET) or sin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ziqi, Aboian, Mariam S., Zhu, Xiaohua, Marquez-Nostra, Bernadette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101155/ https://www.ncbi.nlm.nih.gov/pubmed/35565232 http://dx.doi.org/10.3390/cancers14092103

Ejemplares similares

ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer
por: Li, Ziqi, et al.
Publicado: (2023)

Targeting HER2 in Nuclear Medicine for Imaging and Therapy
por: Massicano, Adriana V. F., et al.
Publicado: (2018)

Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer
por: Fang, Hanyi, et al.
Publicado: (2021)

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent
por: Marquez-Nostra, Bernadette V., et al.
Publicado: (2017)

PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022)

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma
por: Su, David, et al.
Publicado: (2023)

Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine
por: Pyrzynska, Krystyna, et al.
Publicado: (2022)

Review: Receptor Targeted Nuclear Imaging of Breast Cancer
por: Dalm, Simone U., et al.
Publicado: (2017)

New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents
por: Chen, Kuo-Ting, et al.
Publicado: (2022)

Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents
por: Winuprasith, Thunnalin, et al.
Publicado: (2023)

Comparing 3D, 2.5D, and 2D Approaches to Brain Image Auto-Segmentation
por: Avesta, Arman, et al.
Publicado: (2023)

Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer
por: Salvatore, Barbara, et al.
Publicado: (2019)

OTHR-11. Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease
por: Kazarian, Marina, et al.
Publicado: (2021)

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
por: Santini, Daniele, et al.
Publicado: (2015)

Machine Learning Tools for Image-Based Glioma Grading and the Quality of Their Reporting: Challenges and Opportunities
por: Merkaj, Sara, et al.
Publicado: (2022)

Evaluation of (89)Zr-pertuzumab in Breast Cancer Xenografts
por: Marquez, Bernadette V., et al.
Publicado: (2014)

Nuclear medicine imaging in the evaluation of endocrine hypertension
por: Sharma, Punit, et al.
Publicado: (2012)

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications
por: Joshi, Bishnu P., et al.
Publicado: (2018)

Anti-HER2 imaging agents for breast cancer imaging
por: Tolner, B, et al.
Publicado: (2010)

Machine Learning Decision Tree Models for Differentiation of Posterior Fossa Tumors Using Diffusion Histogram Analysis and Structural MRI Findings
por: Payabvash, Seyedmehdi, et al.
Publicado: (2020)

Tocotrienols as an Anti-Breast Cancer Agent
por: Trujillo, Madison, et al.
Publicado: (2021)

Self-attention random forest for breast cancer image classification
por: Li, Jia, et al.
Publicado: (2023)

LGG-09. CORRELATING GENETIC SIGNATURE OF PILOMYXOID ASTROCYTOMAS AND PILOCYTIC ASTROCYTOMAS WITH QUALITATIVE AND QUANTITATIVE MR IMAGING CHARACTERISTICS
por: Fadel, Sandra Abi, et al.
Publicado: (2020)

Delayed Fluorodeoxyglucose Positron Emission Tomography Imaging in the Differentiation of Tumor Recurrence and Radiation Necrosis in Pediatric Central Nervous System Tumors: Case Report and Review of the Literature
por: Wadhwa, Elizabeth L, et al.
Publicado: (2018)

Theranostic Advances in Breast Cancer in Nuclear Medicine
por: Vahidfar, Nasim, et al.
Publicado: (2021)

Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
por: Chen, Wei, et al.
Publicado: (2017)

Molecular Imaging Probes for Diagnosis and Therapy Evaluation of Breast Cancer
por: Meng, Qingqing, et al.
Publicado: (2013)

Characterization of Nuclear Pleomorphism and Tubules in Histopathological Images of Breast Cancer †
por: Peregrina-Barreto, Hayde, et al.
Publicado: (2022)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms
por: Fargette, Christelle, et al.
Publicado: (2023)

Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
por: Parikh, Kaushal, et al.
Publicado: (2014)

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020)

Nuclear Receptor Imaging In Vivo—Clinical and Research Advances
por: Parent, Ephraim E, et al.
Publicado: (2022)

The role of general nuclear medicine in breast cancer
por: Greene, Lacey R, et al.
Publicado: (2015)

The current role of nuclear medicine in breast cancer
por: Vaz, Sofia C., et al.
Publicado: (2023)

Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer
por: Sheikh, Arif, et al.
Publicado: (2017)

Recent Development of Nuclear Molecular Imaging in Thyroid Cancer
por: Liu, Huiting, et al.
Publicado: (2018)

Delivery of gene silencing agents for breast cancer therapy
por: Shen, Haifa, et al.
Publicado: (2013)

Anti-breast Cancer Agents Derived from Plants
por: Levitsky, Dmitri O., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_us6mg0m40pg0shvll6malvhqun